The Promise of Pharmacogenomics
Enrollment options
This 1-hour education program is designed for healthcare professionals and administrators seeking to learn about opportunity to improve medication outcomes using pharmacogenomics (PGx). Upon completion of this self-paced, online modules continuing education can be awarded.
TARGET AUDIENCE
This course is designed for all healthcare professionals, including nurses, nurse practitioners, pharmacists, physicians and physician assistants.
LEARNING MODULES
- What is pharmacogenomics (PGx)
- All about PGx testing
- PGx clinical decision making
- Putting PGx into practice (real-world implementation)
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
|
PLANNING COMMITTEE
 |
Philip Empey, PharmD, PhD, FCCP Associate Professor, Pharmacy and Therapeutics, Associate Director, Institute of Precision Medicine; University of Pittsburgh School of Pharmacy (Program Director) |
 |
James Coons, PharmD, FCCP, FACC, BCCP Professor, Pharmacy and Therapeutics, PGY2 Cardiology Residency Program Director, University of Pittsburgh School of Pharmacy |
 |
Lucas Berenbrok, PharmD, MS, BCACP, TTS Associate Professor, Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy |
 |
Deepak Voora, MD Executive Director, VA National Pharmacogenomics Program VA Central Office, Washington, DC |
 |
Jill Bates PharmD, MS, BCOP, DipACLM, FASHP Deputy Executive Director, VA National Pharmacogenomics Program VA Central Office, Washington, DC |
 |
Trina Walker, DNP, APRN, FNP-C Assistant Professor, Nursing Creighton University |
 |
Nguyen Park, MS, PA-C President and Founder, Society of PAs in Genetics/Genomics |
PRESENTER
 |
Philip Empey, PharmD, PhD, FCCP Associate Professor, Pharmacy and Therapeutics, Associate Director, Institute of Precision Medicine; University of Pittsburgh School of Pharmacy |
CONFLICT OF INTEREST
Dr. Coons discloses that he receives grant/research support from Heart Rhythm Society, and Bristol Myers Squibb Alliance. He is a consultant for Merck, Bristol Myers Squibb, AstraZeneca and Johnson & Johnson.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit. Physician (CME) The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing (CNE) The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours. Physician Assistant (AAPA) The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Other healthcare professionals
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses. Continuing education can be claimed for the above learner groups. Learners must complete the full program (all modules, attain grades of 80% or higher on assessments, and participate in the live session) as well as submit the required information to the CE office (e.g. profile information and evaluations) prior to the deadline to receive continuing education credit. Partial credit will not be awarded.
Released: 2/14/2024ACCREDITATION
DISCLAIMER STATEMENT
HOW TO OBTAIN CONTINUING EDUCATION
Expires: 9/30/2027